
Jan 12 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:
ULTRAGENYX PROVIDES FINANCIAL AND BUSINESS UPDATES AT J.P. MORGAN ANNUAL HEALTHCARE CONFERENCE
2025 REVENUE EXCEEDS GUIDANCE AT $672 MILLION-$674 MILLION
CASH AND INVESTMENTS ABOUT $735 MILLION AS OF DEC 31, 2025
FY2025 REVENUE VIEW $655.6 MILLION -- LSEG IBES DATA
Further company coverage: RARE.O